Halogen bonding--a novel interaction for rational drug design?

Area of Science:

• Computational Chemistry
• Structural Biology
• Drug Design

Background:

• Halogen bonding is a well-established interaction in small molecules.
• Its significance in complex biomolecular systems, particularly protein-ligand interactions, is emerging.
• Understanding these interactions is crucial for molecular recognition and drug development.

Purpose of the Study:

• To investigate the nature and strength of halogen bonding in protein-ligand complexes.
• To compare halogen bonding with classical hydrogen bonding in biological systems.
• To explore the role of halogen bonding in determining molecular conformation within protein active sites.

Main Methods:

• Utilized a two-layer Quantum Mechanics/Molecular Mechanics (QM/MM) ONIOM methodology.
• Analyzed several protein systems complexed with halogenated ligands.
• Performed single-point energy calculations to quantify interaction strengths.

Main Results:

• Observed halogen-oxygen distances significantly shorter than predicted by van der Waals radii.
• Quantified halogen bonding interactions to be comparable in magnitude to hydrogen bonds.
• Determined the interaction strength order: H ≈ I > Br > Cl, consistent with small molecule studies.

Conclusions:

• Halogen bonding is a significant interaction in protein-ligand complexes, influencing conformation.
• The strength of halogen bonding varies predictably with the halogen atom.
• Halogen bonding represents a promising avenue for rational drug design strategies.